Relationship between G protein level with left ventricular systolic function in children with acyanotic heart disease

Herlina Dimiati1, Mira Srikandi2, Te Haypheng3

  • 1Division of Cardiology, Department of Pediatrics, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.

Narra J
|September 16, 2024
PubMed

Insights

This study found no direct relationship between G protein levels and left ventricular systolic function in children with acyanotic congenital heart disease (CHD). Further research with larger sample sizes is recommended to confirm these findings in pediatric cardiology.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Molecular Biology

Background:

  • Heart failure is a critical pediatric condition, often stemming from congenital heart disease (CHD).
  • G proteins are key regulators in cardiovascular system functions, including heart failure.
  • Understanding G protein involvement in pediatric heart conditions is crucial for effective treatment.

Purpose of the Study:

  • To investigate G protein levels in children diagnosed with acyanotic congenital heart disease.
  • To examine the correlation between G protein levels and left ventricular systolic function in this pediatric cohort.

Main Methods:

  • A cross-sectional study involving 38 children (0-18 years) with acyanotic CHD.
  • G protein levels were quantified using the ELISA method.
  • Left ventricular systolic function was assessed, and the Chi-squared test analyzed the relationship with G protein levels.

Main Results:

  • The mean G protein level was 36.25 ng/mL, and mean left ventricular systolic function was 73.1% in the study group.
  • No statistically significant relationship was identified between G protein levels and left ventricular systolic function in children with acyanotic CHD.

Conclusions:

  • The study did not find a direct association between G protein levels and left ventricular systolic function in pediatric acyanotic CHD.
  • Larger sample sizes and inclusion of additional variables are necessary for further investigation and validation of these results.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810